Open AccessSevere pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma
Author(s) -
ShangJu Wu,
WenChien Chou,
Bo-Sheng Ko,
HweiFang Tien
Publication year - 2007
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.10561
Subject(s) - rituximab , medicine , lymphoma , intravascular large b cell lymphoma , cd20 , gastroenterology , oncology
Rituximab improves response to treatment and outcome for patients with CD20+ B-cell lymphoma. Herein, however, we report the occurrence of severe pulmonary complications shortly after rituximab infusion in three patients with the newly diagnosed Asian variant of intravascular lymphoma. It is suggested that patients with this subtype of lymphoma are monitored carefully for possible drug reactions during the use of rituximab.